Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification-Reference-Cited by-同舟云学术

Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification

Published:2023-05 Issue: Volume:116 Page:102558
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Rizzo Mimma,Caliò Anna,Brunelli Matteo,Pezzicoli Gaetano,Ganini Carlo^ORCID,Martignoni Guido,Porta Camillo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference63 articles.

1. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours;Moch;Eur Urol,2022

2. WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist;Caliò;Pathologica,2023

3. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma;Lobo;Histopathology,2022

4. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma;Le;BMC Urol,2020

5. Clear Cell Papillary Renal Cell Carcinoma: New Clinical and Imaging Characteristics;Wang;Urology,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications;European Medical Journal;2023-12-14

2. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma;Current Oncology;2023-10-20

3. Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives;Diagnostics;2023-07-06